ES2032860T3 - Adsorbatos medicamentosos con surfactante y su preparacion. - Google Patents

Adsorbatos medicamentosos con surfactante y su preparacion.

Info

Publication number
ES2032860T3
ES2032860T3 ES198787810167T ES87810167T ES2032860T3 ES 2032860 T3 ES2032860 T3 ES 2032860T3 ES 198787810167 T ES198787810167 T ES 198787810167T ES 87810167 T ES87810167 T ES 87810167T ES 2032860 T3 ES2032860 T3 ES 2032860T3
Authority
ES
Spain
Prior art keywords
surfactant
adsorbates
medication
preparation
medicinal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198787810167T
Other languages
English (en)
Inventor
John Denick, Jr.
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Application granted granted Critical
Publication of ES2032860T3 publication Critical patent/ES2032860T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Ink Jet (AREA)

Abstract

UN ADSORBATO DE MEDICAMENTO Y PROCESO PARA HACERLO. EL ADSORBATO DE MEDICAMENTO COMPRENDE UN SILICATO COMPLEJO DE ALUMINIO Y MAGNESIO QUE HA SORBIDO UN MEDICAMENTO Y UN AGENTE TENSIOACTIVO.
ES198787810167T 1986-03-27 1987-03-23 Adsorbatos medicamentosos con surfactante y su preparacion. Expired - Lifetime ES2032860T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/845,209 US4716033A (en) 1986-03-27 1986-03-27 Medicament adsorbates with surfactant and their preparation

Publications (1)

Publication Number Publication Date
ES2032860T3 true ES2032860T3 (es) 1993-03-01

Family

ID=25294655

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198787810167T Expired - Lifetime ES2032860T3 (es) 1986-03-27 1987-03-23 Adsorbatos medicamentosos con surfactante y su preparacion.

Country Status (12)

Country Link
US (1) US4716033A (es)
EP (1) EP0239541B1 (es)
JP (1) JPH0818974B2 (es)
AT (1) ATE60227T1 (es)
AU (1) AU570872B2 (es)
CA (1) CA1282329C (es)
DE (1) DE3767524D1 (es)
DK (1) DK168267B1 (es)
ES (1) ES2032860T3 (es)
FI (1) FI871314L (es)
HK (1) HK50794A (es)
NZ (1) NZ219641A (es)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4761274A (en) * 1986-03-27 1988-08-02 Warner-Lambert Company Medicament adsorbates of analgesics with complex magnesium aluminum silicate and their preparation
US4717565A (en) * 1986-03-27 1988-01-05 Warner-Lambert Company Process for the preparation of medicament adsorbates
US4758425A (en) * 1986-03-27 1988-07-19 Warner-Lambert Company Medicament adsorbates of antiasthmatics with complex magnesium aluminum silicate and their preparation
US4758424A (en) * 1986-03-27 1988-07-19 Warner-Lambert Company Medicament adsorbates of decongestants with complex magnesium aluminum silicate and their preparation
US4814354A (en) * 1986-09-26 1989-03-21 Warner-Lambert Company Lipid regulating agents
GB8623557D0 (en) * 1986-10-01 1986-11-05 Boots Co Plc Therapeutic agents
FR2627696B1 (fr) * 1988-02-26 1991-09-13 Fournier Innovation Synergie Nouvelle forme galenique du fenofibrate
US4927639A (en) * 1989-02-02 1990-05-22 Warner-Lambert Company Modified release gemfibrozil composition
US4925676A (en) * 1989-02-02 1990-05-15 Warner-Lambert Company Extended release gemfibrozil composition
EP0462067A1 (en) * 1990-06-15 1991-12-18 Warner-Lambert Company Gemfibrozil formulations
US5272137A (en) * 1992-02-14 1993-12-21 Mcneil-Pfc, Inc. Aqueous pharmaceutical suspension for pharmaceutical actives
NO941358L (no) * 1993-04-16 1994-10-17 Mcneil Ppc Inc Vandig farmasöytisk suspensjon og fremgangsmåte for fremstilling derav
US5622980A (en) * 1993-08-17 1997-04-22 Applied Analytical Industries, Inc. Oral compositions of H2-antagonists
US6949264B1 (en) 1996-11-27 2005-09-27 Wm. Wrigley Jr. Company Nutraceuticals or nutritional supplements and method of making
FR2758459B1 (fr) * 1997-01-17 1999-05-07 Pharma Pass Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation
SG71877A1 (en) 1997-12-19 2000-04-18 Johnson & Johnson Consumer Novel powder compositions
US6586023B1 (en) 1998-12-15 2003-07-01 Wm. Wrigley Jr. Company Process for controlling release of active agents from a chewing gum coating and product thereof
US7163705B2 (en) 1998-12-15 2007-01-16 Wm. Wrigley Jr. Company Coated chewing gum product and method of making
US6627234B1 (en) 1998-12-15 2003-09-30 Wm. Wrigley Jr. Company Method of producing active agent coated chewing gum products
US6531114B1 (en) 1999-04-06 2003-03-11 Wm. Wrigley Jr. Company Sildenafil citrate chewing gum formulations and methods of using the same
DE19859231A1 (de) * 1998-12-21 2000-06-29 Kurt Heinz Bauer Schäumende Antacida-Suspensionstabletten
US6773716B2 (en) 1999-04-06 2004-08-10 Wm. Wrigley Jr. Company Over-coated chewing gum formulations
US7935362B2 (en) 1999-04-06 2011-05-03 Wm. Wrigley Jr. Company Over-coated product including consumable center and medicament
US6322806B1 (en) 1999-04-06 2001-11-27 Wm. Wrigley Jr. Company Over-coated chewing gum formulations including tableted center
US6355265B1 (en) 1999-04-06 2002-03-12 Wm. Wrigley Jr. Company Over-coated chewing gum formulations
US6663849B1 (en) 2000-09-01 2003-12-16 Wm. Wrigley Jr. Company Antacid chewing gum products coated with high viscosity materials
US6645535B2 (en) 1999-09-02 2003-11-11 Wm. Wrigley Jr. Company Method of making coated chewing gum products containing various antacids
US6541048B2 (en) 1999-09-02 2003-04-01 Wm. Wrigley Jr. Company Coated chewing gum products containing an acid blocker and process of preparing
US6569472B1 (en) 2000-09-01 2003-05-27 Wm. Wrigley Jr. Company Coated chewing gum products containing antacid and method of making
US9253991B2 (en) 1999-09-20 2016-02-09 Jack Barreca Chewing gum with B vitamins
US6491540B1 (en) 1999-09-20 2002-12-10 Jack Barreca Center-filled supplement gum
US9387168B2 (en) 1999-09-20 2016-07-12 Jack Barreca Chewing gum with tomatidine
US6572900B1 (en) 2000-06-09 2003-06-03 Wm. Wrigley, Jr. Company Method for making coated chewing gum products including a high-intensity sweetener
US7115288B2 (en) 2000-06-09 2006-10-03 Wm. Wrigley Jr. Company Method for making coated chewing gum products with a coating including an aldehyde flavor and a dipeptide sweetener
US6531158B1 (en) 2000-08-09 2003-03-11 Impax Laboratories, Inc. Drug delivery system for enhanced bioavailability of hydrophobic active ingredients
US6444241B1 (en) 2000-08-30 2002-09-03 Wm. Wrigley Jr. Company Caffeine coated chewing gum product and process of making
US6579545B2 (en) 2000-12-22 2003-06-17 Wm. Wrigley Jr. Company Coated chewing gum products containing an antigas agent
CZ20033456A3 (en) * 2001-06-22 2004-07-14 Pfizer Products Inc. Pharmaceutical compositions comprising adsorbates of amorphous drug
JP2005523262A (ja) * 2002-02-01 2005-08-04 ファイザー・プロダクツ・インク 薬物及び親油性ミクロ相形成物質の非晶質分散物の医薬組成物
AU2003230190A1 (en) * 2002-02-20 2003-09-09 Strides Arcolab Limited Orally administrable pharmaceutical formulation comprising pseudoephedrine hydrochloride and process for preparing the same
US20030158264A1 (en) * 2002-02-20 2003-08-21 Ramachandran Radhakrishnan Orally administrable pharmaceutical formulation comprising ephedrine hydrochloride and process for preparing the same
US20040033257A1 (en) * 2002-05-30 2004-02-19 Strides Inc. Pharmaceutical formulation in a drug delivery system and process for preparing the same
ATE540671T1 (de) * 2003-08-04 2012-01-15 Bend Res Inc Pharmazeutische zusammensetzungen von adsorbaten von amorphen arzneimitteln und lipophilen mikrophasen-bildenden materialien
WO2005026048A1 (ja) * 2003-09-11 2005-03-24 Taiyo Kagaku Co., Ltd. 物質担持多孔質シリカ
EP1865790A1 (en) * 2005-02-25 2007-12-19 Cadbury Adams USA LLC Edible compositions containing gelling silicates
US7767248B2 (en) 2007-02-02 2010-08-03 Overly Iii Harry J Soft chew confectionary with high fiber and sugar content and method for making same

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2523204A (en) * 1947-08-02 1950-09-19 Vanderbilt Co R T Colloidal silicate emulsifying composition
US2678902A (en) * 1950-11-06 1954-05-18 Colgate Palmolive Co Hand lotion
US3140978A (en) * 1961-11-02 1964-07-14 Hoffmann La Roche Pharmaceutical composition containing complex magnesium aluminum silicate
US3248290A (en) * 1962-08-09 1966-04-26 Hoffmann La Roche Antitussive compositions
US3352752A (en) * 1963-07-25 1967-11-14 Tintex Corp Intestinal adsorbent compositions
US3337402A (en) * 1963-09-03 1967-08-22 Hoffmann La Roche Stable and palatable pharmaceutical composition
US3432593A (en) * 1963-09-18 1969-03-11 Key Pharm Inc Delayed and sustained release type pharmaceutical preparation
US3567819A (en) * 1969-01-30 1971-03-02 Hoffmann La Roche Cold tablet
US3636200A (en) * 1969-06-09 1972-01-18 Hoffmann La Roche Pharmaceutical suspension
DE2146168A1 (de) * 1971-09-15 1973-03-29 Antibiotice Iashi Fab De Verfahren zur herstellung von hydrophilen salben
US4029797A (en) * 1973-06-20 1977-06-14 Fisons Corporation Process of making cough syrup with masked noscapine
US3998973A (en) * 1975-04-07 1976-12-21 R. T. Vanderbilt Company, Inc. Thickening composition
US4116866A (en) * 1977-07-01 1978-09-26 N L Industries, Inc. Organophilic clay gellant
US4145440A (en) * 1977-08-18 1979-03-20 The Upjohn Company Liquid suspension of an aluminum salt of ibuprofen
DE2922670C2 (de) * 1979-06-02 1982-09-09 Battelle-Institut E.V., 6000 Frankfurt Kaubare Arzneiform
JPS58213073A (ja) * 1982-06-07 1983-12-10 Masatoshi Yamada 油状物質の固形化法
US4581232A (en) * 1983-07-20 1986-04-08 Warner-Lambert Company Magnesium trisilicate suitable for preparation of medicament adsorbates
US4632822A (en) * 1983-07-20 1986-12-30 Warner-Lambert Company Magnesium trisilicate suitable for preparation of medicament adsorbates of antiasmatics
US4632821A (en) * 1983-07-20 1986-12-30 Warner-Lambert Company Magnesium trisilicate suitable for preparation of medicament adsorbates of decongestants
US4632823A (en) * 1983-07-20 1986-12-30 Warner-Lambert Company Magnesium trisilicate suitable for preparation of medicament adsorbates of appetite suppressants
US4717565A (en) * 1986-03-27 1988-01-05 Warner-Lambert Company Process for the preparation of medicament adsorbates
US4711774A (en) * 1986-03-27 1987-12-08 Warner-Lambert Company Medicament adsorbates with complex magnesium aluminum silicate and their preparation

Also Published As

Publication number Publication date
EP0239541A2 (en) 1987-09-30
FI871314A0 (fi) 1987-03-25
AU7069087A (en) 1987-10-01
DK153487A (da) 1987-09-28
DK153487D0 (da) 1987-03-26
NZ219641A (en) 1990-03-27
US4716033A (en) 1987-12-29
DE3767524D1 (de) 1991-02-28
HK50794A (en) 1994-05-27
ATE60227T1 (de) 1991-02-15
AU570872B2 (en) 1988-03-24
FI871314A7 (fi) 1987-09-28
CA1282329C (en) 1991-04-02
DK168267B1 (da) 1994-03-07
JPH0818974B2 (ja) 1996-02-28
FI871314L (fi) 1987-09-28
JPS62234016A (ja) 1987-10-14
EP0239541B1 (en) 1991-01-23
EP0239541A3 (en) 1987-12-23

Similar Documents

Publication Publication Date Title
ES2032860T3 (es) Adsorbatos medicamentosos con surfactante y su preparacion.
ES2040760T3 (es) Procedimiento para preparar adsorbatos medicamentosos con silicato complejo de magnesio-aluminio.
AU458540B2 (en) Purification of combustion products before discharge into the atmosphere
ES2057124T3 (es) Producto terapeutico para el tratamiento de estados peri- o post-menopausicos.
CA932638A (en) Method of making composites and products produced thereby
AU3460571A (en) Composition and method for treatment of hepatic disease and mental fatigue
AR224086A1 (es) Procedimiento,receptaculo final y dispositivo para acelerar la disolucion de medicamentos liofilizados poco solubles
ES2101317T3 (es) Medicamento para aumentar el nivel de testosterona.
EP0661052A4 (en) PHARMACEUTICAL PREPARATION CONTAINING A PROSTAGLANDIN COMPOUND TO BE ADMINISTERED RECTALLY OR VAGINALLY.
DE3272602D1 (en) Solid galenic form for oral administration and process for its preparation
IL36045A (en) 3,20-dioxo-17alpha,21-dimethyl-19-norpregna-4,9 diene and process of preparation
ES2046270T3 (es) Un procedimiento para fabricar una composicion farmaceutica en forma de una tableta de compresion multiple.
DK325387A (da) 4-benzyloxy-3-pyrrolin-2-on-1-yl-acetamid samt dets fremstilling og anvendelse
CA1022099A (en) Process for the preparation of technical white oils and medicinal oils
IL36487A0 (en) Derivatives of phenyl-azolyl-fatty acids,their production and their use as medicines
CA923135A (en) Process for the manufacture of meal and oil from oily fish
CA947315A (en) Process for the simultaneous preparation of trichloroacrylic acid and an organic acid chloride
CA973556A (en) Process for the preparation of 2 thion-oxazolidinone-5 and derivatives thereof
FR1432344A (fr) Procédé de décoration, notamment de bougies, cierges et analogues
AU256160B2 (en) The production of magnesium base materials and products thereof
CA957370A (en) Compounds of the 1h-or respectively 2h-indazolone-3 and process of producing such compounds
IL30923A0 (en) Process for the preparation of 4,4'-dibromobenzilic acid and its alkyl esters
AU1304762A (en) The production of magnesium base materials and products thereof
JPS51120896A (en) Buffer structure
CA1030872A (en) Process for the preparation of influenza vaccines and the active principle thereof

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 239541

Country of ref document: ES